PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Oxetacaine manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

oxetacaine + aluminium hydroxide + magnesium hydroxide

Oral suspension 10 mg + 291 mg + 98 mg - 100 ml, 200 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #15604
An India-based pharmaceutical manufacturer focused on developing, manufacturing and marketing pharmaceutical products across generics, specialty care and over-the-counter segments, with a portfolio of more than 300 pharmaceutical products spanning therapeutic areas such as cardiology, respiratory care, diabetes, pain management and anti-infectives. The company highlights end-to-end capabilities from product development and R&D through contract manufacturing and licensing for domestic and international partners, supported by stringent quality systems. For quality credentials, the site states compliance with WHO-GMP norms and ISO 9001:2015 certification, reflecting a structured approach to safe, effective and affordable pharmaceutical products.

Manufacturer usually replies in 13 days

magaldrate + oxetacaine + simethicone

Oral suspension 540 mg + 10 mg + 50 mg / 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18273
India-based pharmaceutical company focused on supplying Rx generics to sub-Saharan African and other emerging healthcare markets. Oral solids, liquids, and semi-solids cover essential therapy areas including infections, malaria, and general medicine aligned with WHO guidelines. Quality-compliant manufacturing is aligned with regulatory requirements of target African markets.

Manufacturer usually replies in 15 days

sucralfate + oxetacaine

Oral suspension 1 g + 20 mg / 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18273
India-based pharmaceutical company focused on supplying Rx generics to sub-Saharan African and other emerging healthcare markets. Oral solids, liquids, and semi-solids cover essential therapy areas including infections, malaria, and general medicine aligned with WHO guidelines. Quality-compliant manufacturing is aligned with regulatory requirements of target African markets.

Manufacturer usually replies in 15 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.